fluorocholine (18f) cis bio international 225 mbq/ml inj. sol. i.v. vial
cis bio international - fluorocholine (18 f) 225 mbq/ml - solution for injection - 225 mbq/ml - fluorocholine (f-18) 225 mbq/ml - fluoromethylcholine (18f)
fluorodopa 18f cis bio international 90 mbq/ml inj. sol. i.v. vial
cis bio international - fluorodopa (18 f) 90 mbq/ml - solution for injection - 90 mbq/ml - fluorodopa (f-18) - fluorodopa (18f)
sodium fluoride (18f) life radiopharma 0.1 gbq/ml - 4 gbq/ml inj. sol. i.v. vial
life radiopharma berlin gmbh - sodium fluoride (18 f) 100 mbq/ml - 4000 mbq/ml - solution for injection - 0,1-4 gbq/ml - sodium fluoride (f-18) - sodium fluoride (18f)
pylclari
curium pet france - piflufolastat (18f) - prostatic neoplasms - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent.pylclari is indicated for use with positron emission tomography (pet).
fludeoxyglucose (18f) karolinska 450-11250 mbq/ml injektionsvätska, lösning
fludeoxyglucose (18f) rtm 200 mbq/ml, injektionslösung
pca (18f) fludeoxyglucose injektionsvæske, i.v.
fludeoxyglucose (18f) sahlgrenska 1-110 gbq injektionsvätska, lösning
fludeoxyglucose (18f) akademiska sjukhuset 0,9 gbq/ml - 4,5 gbq/ml injektionsvätska, lösning
fludeoxyglucose (18f) ujv